# Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure

Study · id `cardio:ct-nct05650541` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05650541](<https://clinicaltrials.gov/study/NCT05650541>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05650541

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1200 participants.

## Technical summary

Registry record NCT05650541. Randomized; single masking; primary purpose prevention. Start 2023-09-22 (actual); primary completion 2026-12-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 1200 participants (planned count; ClinicalTrials.gov record NCT05650541, source copy `cardio:ctgov-nct05650541-2026-08-19`, retrieved 2026-10-26)
- Started: 2023-09-22 (actual) (ClinicalTrials.gov record NCT05650541, source copy `cardio:ctgov-nct05650541-2026-08-19`, retrieved 2026-10-26)
- Primary completion: 2026-12-01 (anticipated) (ClinicalTrials.gov record NCT05650541, source copy `cardio:ctgov-nct05650541-2026-08-19`, retrieved 2026-10-26)
- Completion: 2026-12-01 (anticipated) (ClinicalTrials.gov record NCT05650541, source copy `cardio:ctgov-nct05650541-2026-08-19`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT05650541, source copy `cardio:ctgov-nct05650541-2026-08-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05650541-2026-08-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure
- Acronym: BETA
- Condition: Heart Failure
- Intervention (Device): CardioPumlonary Management System
- Lead sponsor: Analog Device, Inc.
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)

## Provenance

Content hash: 84b5e6564a9a1e4419dc8b45d8f46117324efd91c2b23033ac11186ad4b044d0
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
